Liz-anne A. Lewsley
Glasgow, SCT, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Hedgehog Inhibitor and Paclitaxel: A Phase I Trial of the Oral Hedgehog inhibitor Taladegib in Combination with Weekly Paclitaxel in Patients with Advanced Solid Tumours.
Journal: Investigational new drugs
Published: March 03, 2026
Correction: Relative telomere length and senescence-associated inflammatory cytokines as blood-based prognostic markers in patients with advanced or resectable gastro-oesophageal adenocarcinoma.
Journal: British journal of cancer
Published: December 19, 2025
Identifying high-risk relapse in early-stage I to II ovarian cancer using the CA125 ELIMination rate constant K (KELIM) score: a Gynecologic Cancer InterGroup individual patient-data meta-analysis.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: July 25, 2025
Relative telomere length and senescence-associated inflammatory cytokines as blood-based prognostic markers in patients with advanced or resectable gastro-oesophageal adenocarcinoma.
Journal: British journal of cancer
Published: April 10, 2025
Author Correction: The copy number and mutational landscape of recurrent ovarian high-grade serous carcinoma.
Journal: Nature communications
Published: September 26, 2023
Survival and modelled cancer antigen-125 ELIMination rate constant K score in ovarian cancer patients in first-line before poly(ADP-ribose) polymerase inhibitor era: A Gynaecologic Cancer Intergroup meta-analysis.
Journal: European journal of cancer (Oxford, England : 1990)
Published: April 26, 2023
CA-125 Early Dynamics to Predict Overall Survival in Women with Newly Diagnosed Advanced Ovarian Cancer Based on Meta-Analysis Data.
Journal: Cancers
Published: February 04, 2023
The copy number and mutational landscape of recurrent ovarian high-grade serous carcinoma.
Journal: Nature communications
Published: October 21, 2022
Correction to: Durvalumab (MEDI 4736) in combination with extended neoadjuvant regimens in rectal cancer: a study protocol of a randomised phase II trial (PRIME-RT).
Journal: Radiation oncology (London, England)
Published: December 03, 2021
Durvalumab (MEDI 4736) in combination with extended neoadjuvant regimens in rectal cancer: a study protocol of a randomised phase II trial (PRIME-RT).
Journal: Radiation oncology (London, England)
Published: April 06, 2021
Glasgow Early Treatment Arm Favirpiravir (GETAFIX) for adults with early stage COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Journal: Trials
Published: November 06, 2020
Last Updated: 09/26/2026